Based on these findings, we speculate that S100A4 stimulates pancreatic cancer progression directly by promoting tumorigenic potential of cancer cells and indirectly by modulating tumor microenvironment including angiogenesis. Here, S100A4 is linked to pancreatic neoplasm.